1. Home
  2. GPCR vs NRP Comparison

GPCR vs NRP Comparison

Compare GPCR & NRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • NRP
  • Stock Information
  • Founded
  • GPCR 2016
  • NRP 2002
  • Country
  • GPCR United States
  • NRP United States
  • Employees
  • GPCR N/A
  • NRP N/A
  • Industry
  • GPCR
  • NRP Coal Mining
  • Sector
  • GPCR
  • NRP Energy
  • Exchange
  • GPCR Nasdaq
  • NRP Nasdaq
  • Market Cap
  • GPCR 1.1B
  • NRP 1.3B
  • IPO Year
  • GPCR 2023
  • NRP N/A
  • Fundamental
  • Price
  • GPCR $21.76
  • NRP $97.47
  • Analyst Decision
  • GPCR Strong Buy
  • NRP
  • Analyst Count
  • GPCR 8
  • NRP 0
  • Target Price
  • GPCR $79.29
  • NRP N/A
  • AVG Volume (30 Days)
  • GPCR 755.1K
  • NRP 21.1K
  • Earning Date
  • GPCR 05-08-2025
  • NRP 05-06-2025
  • Dividend Yield
  • GPCR N/A
  • NRP 4.30%
  • EPS Growth
  • GPCR N/A
  • NRP N/A
  • EPS
  • GPCR N/A
  • NRP 10.41
  • Revenue
  • GPCR N/A
  • NRP $229,909,000.00
  • Revenue This Year
  • GPCR N/A
  • NRP N/A
  • Revenue Next Year
  • GPCR N/A
  • NRP N/A
  • P/E Ratio
  • GPCR N/A
  • NRP $9.41
  • Revenue Growth
  • GPCR N/A
  • NRP N/A
  • 52 Week Low
  • GPCR $13.22
  • NRP $81.74
  • 52 Week High
  • GPCR $62.74
  • NRP $113.04
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 39.75
  • NRP 50.06
  • Support Level
  • GPCR $22.09
  • NRP $92.00
  • Resistance Level
  • GPCR $24.98
  • NRP $98.02
  • Average True Range (ATR)
  • GPCR 1.64
  • NRP 2.62
  • MACD
  • GPCR -0.54
  • NRP 0.32
  • Stochastic Oscillator
  • GPCR 4.64
  • NRP 75.03

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.

Share on Social Networks: